Background: Failure rate for left ventricular (LV) lead implantation in cardiac
resynchronization therapy (CRT) is up to 12%. The use of segmentation tools, advanced …

Cardiac resynchronization therapy (CRT) offers proven benefit to patients with refractory
symptomatic chronic heart failure (New York Heart Association Class III or IV), severe left …

Cardiac Resynchronization Therapy (CRT) has been found to improve quality of life, reduce
heart-failure related hospitalizations, and prolong survival in patients with New York Heart …

Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart
failure with impaired left ventricular (LV) systolic function and a wide QRS complex. Early …

Cardiac resynchronization therapy (CRT) is a standard treatment for patients with heart
failure. However, 30–40% of the patients having CRT do not respond to CRT with improved …

Although cardiac resynchronization therapy (CRT) has been established as an important
treatment modality for heart failure patients, at least one third of CRT recipients do not …

Cardiac resynchronisation therapy (CRT) is common treatment for congestive heart failure
(HF) with decreased LV function and wide QRS complex. Its foundations are set in the …

Cardiac resynchronization therapy (CRT) has been established as an adjunctive treatment
for patients with left ventricular systolic dysfunction and medically refractory heart failure with …

Background Cardiac resynchronization therapy (CRT) is an established treatment in heart
failure patients. However, a large proportion of patients remain nonresponsive to this pacing …

Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart
failure and left ventricular systolic dysfunction. For many years, cardiac mechanical …